Screening Methods for Elemental Impurities: Proposed Compendial Requirements
Event Date: June 14, 2012 at 11:00 AM EDT for North America and on June 21, 2012 at 11:00 AM CET for Europe

The revised US Pharmacopeia revised chapters on elemental impurity limits and procedures (<232> and <233>) are to be published as final in June 2012 and will become official by the end of the year. Conformance to the standards will be required starting May 1, 2014, and companies are already beginning to make changes for implementation. At the same time, the International Conference on Harmonization (ICH) working group on elemental impurities, ICH Q3D, is continuing to develop a harmonized approach for controlling these impurities, including risk-assessment recommendations and safety limits for specific metals, that meet testing and regulatory filing requirements at the global level. This webinar will focus on the quantitative screening methods and procedures for detecting elemental impurities based on the new USP chapter (ICP-based tests versus qualitative colorimetric tests). Instrumentation, key challenges, best practices, and will be addressed.


Angie Drakulich

Editorial Director
Pharmaceutical Technology / Pharmaceutical Technology Europe/ BioPharm International


Thomas Devadder

Senior Analyst
SGS Life Science Services, Germany

Kahkashan Zaidi PhD
Senior Scientist
US Pharmacopeia

Nancy Lewen
US Pharmacopeia Elemental Impurities Advisory Panel Member, and Principal Scientist
Bristol-Myers Squibb

This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Jamie Carpenter,

Register for this FREE Webcast!

 If you have previously registered for this event, please login to the archive below:

Registration is required to attend this event. Please register now.
First Name*
Last Name*
Job Title*
Organization Name*
Organization Address*
Organization Address 2
State or Province*
Zip/Postal Code*
E-mail address*
Work Phone*
What does your group outsource? (Please check all that apply.)*
Container testing (including extractables and leachables)
Method development & validation
Biopharmaceutical/large molecule testing
Stability studies
Do not outsource
Would you like to receive information on future SGS sponsored seminars, webcasts, news and events?*
What future webcast topics would be of interest to you?
You must have javascript and cookies enabled to complete registration.
Please enable Cookies in your browser before registering for the webcast.
*Denotes required.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395.

Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Privacy Policy